Trial intelligence / Profile preview

Effect of fasting glycemia normalization with intensive insulin therapy on restenosis after peripheral angioplasty in type 2 diabetes

2008-000686-30Phase 4Terminated

Sponsor
IRCCS Ospedale San Raffaele
Start
Feb 2008
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4 trial of insulin glargine, insulin glulisine, metformin and human insulin in type 2 diabetes mellitus (T2DM) and arteriosclerosis obliterans, sponsored by IRCCS Ospedale San Raffaele. Started Feb 2008; status: terminated.

02

Drugs

insulin glargineinsulin glulisinemetforminhuman insulin
03

Conditions

type 2 diabetes mellitus (T2DM)arteriosclerosis obliterans

Beyond the preview

Go deeper on 2008-000686-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000686-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call